Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes by Eby EL, Van Brunt K, Brusko C, Curtis B, Lage MJ

Get full text

Differences in persistence by class of oral therapy for the treatment of type 2 diabetes by McGovern, AP, Hinton, H, Curtis, BH, van Brunt, K, Calderara, S, de Lusignan, S

What are the HbA(1c) thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care? by Hinton, W, McGovern, AP, Whyt, M, Curtis, BH, McCullough, K, van Brunt, K, Calderara, S, de Lusignan, S

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases by Matza LS, Cong Z, Chung K, Stopeck A, Tonkin K, Brown J, Braun A, Van Brunt K, McDaniel K

Get full text